Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Dec 29, 2023
Trader Robot Alchemy: $ZOM's 6.22% Boost Unveiled

Trader Robot Alchemy: $ZOM's 6.22% Boost Unveiled

In the fast-paced world of stock trading, artificial intelligence (AI) has become a game-changer, and the recent performance of AI trading robots in the "Swing Trader, Popular Stocks: Short Bias Strategy (TA&FA)" is a testament to their effectiveness. Specifically, these bots achieved an impressive +6.22% gain while trading ZOM over the previous week. Let's delve into the technical and fundamental analysis to better understand the factors driving this success.

ZOM's Uptrend:

ZOM has been on a noteworthy uptrend, experiencing a growth of +2.35% over three consecutive days as of December 26, 2023. Traditionally, a three-day upward movement is considered a bullish sign in technical analysis. Historical data indicates that in 188 out of 224 similar instances, the price continued to rise within the following month, suggesting an 84% probability of a sustained upward trend.

Market Cap Overview:

To gain a broader perspective, let's examine ZOM's market capitalization in comparison to the Pharmaceuticals: Other Industry. The average market capitalization within this industry stands at 2.78B, with a range from 246 to 82.08B. Notably, ZTS leads the pack with the highest valuation at 82.08B, while PEMTF holds the lowest valuation at 246.

High and Low Price Movement:

Understanding price movements is crucial for investors. Across all stocks in the Pharmaceuticals: Other Industry, the average weekly price growth is 3%, with a monthly average of 28% and a quarterly average of -5%. Notable mentions include UPC, experiencing the highest weekly growth at 68%, and CHBRF facing the most significant fall at -49%.

Volume Analysis:

Volume is another key indicator in stock analysis. Across all stocks in the Pharmaceuticals: Other Industry, the average weekly volume growth is -32%, with a monthly average of -58% and a quarterly average of 15%. It's essential to note the contrasting trends between price and volume growth, providing valuable insights for traders and investors.

Summary:

The success of AI trading bots in generating a +6.22% gain with ZOM highlights the potential of leveraging technology in stock trading. ZOM's positive uptrend, coupled with insights into market capitalization, price movements, and volume, offers a comprehensive view for investors seeking opportunities in the Pharmaceuticals: Other Industry. As the financial landscape continues to evolve, staying informed and adapting strategies to emerging trends becomes increasingly crucial for successful trading.

Related Ticker: ZOMDF

ZOMDF in upward trend: price expected to rise as it breaks its lower Bollinger Band on March 03, 2026

ZOMDF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 39 cases where ZOMDF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

ZOMDF moved above its 50-day moving average on March 11, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ZOMDF advanced for three days, in of 222 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 40 cases where ZOMDF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on February 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ZOMDF as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ZOMDF turned negative on February 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for ZOMDF crossed bearishly below the 50-day moving average on March 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZOMDF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ZOMDF entered a downward trend on March 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ZOMDF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.080) is normal, around the industry mean (14.063). P/E Ratio (0.000) is within average values for comparable stocks, (40.762). ZOMDF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.593). ZOMDF's Dividend Yield (0.000) is considerably lower than the industry average of (0.020). P/S Ratio (4.388) is also within normal values, averaging (35.460).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZOMDF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.63B. The market cap for tickers in the group ranges from 1.86K to 198.3B. ABT holds the highest valuation in this group at 198.3B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was -2%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was -1%. CLPT experienced the highest price growth at 25%, while OWLT experienced the biggest fall at -54%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was 99%. For the same stocks of the Industry, the average monthly volume growth was -15% and the average quarterly volume growth was -1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 78
Price Growth Rating: 64
SMR Rating: 86
Profit Risk Rating: 95
Seasonality Score: -8 (-100 ... +100)
View a ticker or compare two or three
ZOMDF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a company that develops medication for animals

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interact to see
Advertisement
Financial Learning Models (FLMs) and machine learning (ML) to operate at unprecedented speeds. These agents, now optimized for 5-minute (M5) timeframes, have demonstrated extraordinary annualized returns, with the top agent exceeding +160%.
AI-Driven Market Insights A.I.dvisor’s latest analysis compares SPY and VOO, two leading ETFs, revealing near-identical year-to-date (YTD) gains of 9.82% for SPY and 9.87% for VOO, a 99% parity.
Tickeron, a leader in AI-driven financial tools, today announced exceptional trading results from its AI Trading Agent focused on Hubbell Incorporated (HUBB). The agent, operating on a 5-minute timeframe, delivered a +105% annualized return, starting from an initial balance of $100,000.
#artificial_intelligence
Tickeron, a leader in AI-driven financial technology, today announced the launch of its advanced AI Trading Agents, delivering real-time trading signals and sophisticated money management for retail and institutional traders. Powered by Financial Learning Models (FLMs) and machine learning, these agents operate across 5-, 15-, and 60-minute timeframes, achieving annualized returns of up to 145% on select portfolios.
#artificial_intelligence
Tickeron, a leading innovator in AI-driven financial technology, today announced the exceptional performance of its AI Trading Agents, achieving annualized returns of up to 162%, profitable trade percentages as high as 90.51%, and a robust profit factor across multiple assets.
#artificial_intelligence
Tickeron, a leading innovator in AI-driven financial technology, proudly announces the exceptional performance of its AI Trading Agents, delivering annualized returns of up to 188% on a 5-minute timeframe.
#artificial_intelligence
Tickeron, a leader in AI-driven financial tools, today announced the launch of its advanced Pattern Search Engine (PSE), a revolutionary platform that scans 39 distinct trading patterns across stocks, penny stocks, ETFs, crypto, and forex.
#artificial_intelligence
AI trading bots represent the pinnacle of financial technology innovation, transforming how traders and investors interact with global markets.
#artificial_intelligence
As a financial analyst, writer, and AI specialist, I've always pushed for innovations that merge artificial intelligence with actionable trading tools. In the fast-paced world of modern markets, where volatility demands quick decisions, Tickeron's new "My Trades Aggregator (from AI Robots Followed)" aggregator stands out as a revolutionary feature.
#artificial_intelligence#trading
Tickeron, a leading provider of AI-driven trading solutions, is thrilled to announce the exceptional performance of its AI Trading Agents, delivering outstanding results across multiple high-profile stocks.
#artificial_intelligence
Tickeron, a leader in AI-driven financial technologies, today announced groundbreaking results from its AI Crypto Trading Virtual Agents. These innovative tools provide real-time trading signals, integrated money management, and customizable balances, all powered by advanced machine learning algorithms operating on 5-, 15-, and 60-minute timeframes.
#artificial_intelligence
Tickeron, a leading innovator in AI-driven financial technologies, today announced the launch of its advanced AI Trading Brokerage Agents. These cutting-edge tools deliver real-time trading signals powered by machine learning, utilizing tick-level brokerage data and precise trade amounts across 5-, 15-, and 60-minute timeframes.
#artificial_intelligence
This remarkable rally represents far more than typical market volatility – it signals a fundamental transformation in investor sentiment toward AI connectivity infrastructure and the critical role of semiconductor-based solutions in enabling next-generation artificial intelligence systems
Tickeron, a leader in AI-driven financial tools, today announced the launch of its comprehensive subscription package combining AI Trading Robots for cryptocurrencies with Real-Time Patterns (RTP) analysis.
#artificial_intelligence
Kinross Gold Corporation (KGC), a leading Canada-based gold producer, yielded approximately 2.1 million gold equivalent ounces in 2024.
#artificial_intelligence
Tickeron, a leader in AI-driven financial technologies, today announced impressive results from its AI Trading Agent focused on the iShares U.S. Aerospace & Defense ETF (ITA). Over 123 days, the agent achieved an annualized return of +48%, generating $14,104 in closed trades profit and loss (P/L).
#artificial_intelligence
Tickeron, a pioneer in AI-powered trading solutions, today unveiled groundbreaking results from its 5-minute AI Trading Agent focused on Hubbell Incorporated (HUBB). In just 68 days, the agent delivered an impressive +98% annualized return and $12,899 in closed trades profit/loss (P/L), showcasing the transformative power of machine learning in stock trading.
#artificial_intelligence
In the fast-paced world of stock trading, where market volatility can swing fortunes overnight, Tickeron emerges as a beacon for investors seeking reliable guidance. As a leading provider of AI-powered trading solutions,
#artificial_intelligence
The company's journey from a struggling clean energy stock trading near multi-year lows to a market leader commanding a $12.9 billion valuation demonstrates the convergence of technological breakthroughs, strategic partnerships, regulatory tailwinds, and the explosive growth of AI-driven data centers that require reliable, on-site power solutions.
Palantir Technologies (NASDAQ: PLTR) has delivered one of the most remarkable performances in the technology sector during 2025, with its stock price surging approximately 145% from the April 7, 2025 low of $66.12 to the September 9, 2025 closing price of $162.36.